# Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects

> **NCT01390714** · PHASE1 · COMPLETED · sponsor: **Eisai Co., Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Gastroesophageal Reflux Disease

## Interventions

- **DRUG:** E3710
- **DRUG:** E3710

## Key facts

- **NCT ID:** NCT01390714
- **Lead sponsor:** Eisai Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2012-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01390714

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01390714, "Pharmacodynamic and Pharmacokinetic Study of E3710 Following Oral Administration to Healthy, Male, Japanese Subjects". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01390714. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*